Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Clinical trial NCT00130702 · COMPLETED
Trial details
- NCT number
- NCT00130702
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.